Aggressive variants of papillary thyroid carcinoma (e.g., tall cell, diffuse sclerosing, and hobnail) and mutations such as BRAF V600E and TERT promoter are also associated with increased tumor aggressiveness and RAI-R disease [6,7]. This evidence concerns the gene BRAF and thyroid gland papillary carcinoma.